We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

General News

Which Four Overbought Stocks With RSI Above 70 Report Next, Starting With V.F. Corporation (NYSE:VFC)?

The market is paying for a Vans recovery that earnings have not yet shown. V.F. Corporation rose 13.57% in a week, and what separates it from the other three is an identifiable trigger: JPMorgan upgraded the shares to neutral on October 9, 2026, then …

Vinay Lochav | 16 October 2026

Which of Four Heavily Shorted Stocks, Led by Ondas (NASDAQ:ONDS) at 39.25% of Float, Is Easiest to Squeeze?

Short interest is shares sold short divided by the shares available to trade, and days to cover divides the same position by average daily volume. Ondas leads on the first measure and ranks second lowest on the second, so a squeeze would be quick …

Vinay Lochav | 16 October 2026

Is Quantum Computing Inc (NASDAQ:QUBT) the Heavily Shorted AI Stock With Cash Worth 86% of Its Market Value?

SoundHound is the only name here with revenue growth that the market already treats as proven, and shorts are betting on the price anyway. What separates it is scale: second quarter revenue of USD 61.9 million rose 45%, and 2026 guidance was raised to …

Vinay Lochav | 16 October 2026

Which of Four Biotechs With 26.39% to 32.19% of Float Short Reports Data First, Led by Intellia (NASDAQ:NTLA)?

A short position into an FDA date is a bet that approval is priced in or that the market sells the news. What separates Intellia is the longest runway to a decision: March 10, 2027 is 145 days away, own arithmetic from October 16, …

Vinay Lochav | 16 October 2026

Which Four Clean Energy and Power Stocks Have 29.17% to 30.60% of Float Short, Led by FuelCell Energy (NASDAQ:FCEL)?

FuelCell is a pre-scale manufacturer financed by equity, and shorts added after a documented miss. What separates it from the other three is that the pressure in the filings reviewed is dilution and production, not debt. Shares short rose 23.89% to 24,900,440 between August …

Vinay Lochav | 16 October 2026

Which Short Is Most Crowded: Quantum Computing Inc (NASDAQ:QUBT) at 29.75% or CleanSpark at 29.71% of Float?

A bitcoin miner is being repriced as a leveraged data center developer, and the quote shows it. CleanSpark (NASDAQ:CLSK) traded at USD 8.96 on October 16, 2026, down 4.12%, for a market capitalisation of USD 2.30 billion and 27.1% below its USD 12.29 close …

Vinay Lochav | 16 October 2026

Which Stock Is Hardest to Cover: Tango Therapeutics (NASDAQ:TNGX) at 12.5 Days or Three Rivals at 9.5 to 9.7?

One share in four is sold short ahead of a binary data event. Tango Therapeutics (NASDAQ:TNGX) quoted USD 22.66 on October 16, 2026, down 0.20%, for a USD 3.82 billion market capitalisation, with no company-specific catalyst identified for the session. Days to cover of …

Vinay Lochav | 16 October 2026

Why Do Upstart (NASDAQ:UPST) and Sunrun Both Have 29.36% of Float Sold Short Before November Earnings?

The market is asking whether an AI lending platform can grow without holding credit risk. Upstart (NASDAQ:UPST) quoted USD 24.54 on October 16, 2026, down 0.85%, for a USD 2.39 billion market capitalisation. No company-specific catalyst was identified in the filings and releases reviewed …

Vinay Lochav | 16 October 2026

Why Are Novavax (NASDAQ:NVAX) Down 10.88% and Recursion Down 8.18% While Shorts Hold Heavy Positions?

The market traded outbreak headlines, though the company has no plague vaccine. Novavax (NASDAQ:NVAX) rose 20.08% on October 5, 2026, to USD 12.56 as shorts covered after a Vaxcyte late-stage pneumonia vaccine result and unconfirmed reports of a suspected plague case in Russia. The …

Vinay Lochav | 16 October 2026

Which Short Squeeze Has the Nearest Catalyst: Tango Therapeutics (NASDAQ:TNGX) With ESMO Data Seven Days Away?

The data event is seven days away, and one share in four is sold short. Tango Therapeutics (NASDAQ:TNGX) quoted USD 22.66 on October 16, 2026, down 0.20%, for a USD 3.82 billion market capitalisation, with no company-specific catalyst identified for the session. The June …

Vinay Lochav | 16 October 2026
Support

Hi! How can we help you today?

Loading…